V. Banks

First name
V.
Last name
Banks
Czira, A. ., Banks, V. ., Requena, G. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. . (2024). Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B(2)-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ Open, 14, e072361. http://doi.org/10.1136/bmjopen-2023-072361
Kujawski, S. A., Banks, V. ., Casey, C. S., Drysdale, S. B., Patel, A. ., Massey, O. ., … Pawaskar, M. . (2023). The Clinical and Economic Burden of Antibiotic Use in Pediatric Patients with Varicella Infection: a Retrospective Cohort Analysis of Real-World Data in England. J Infect Dis. http://doi.org/10.1093/infdis/jiad420
Requena, G. ., Czira, A. ., Banks, V. ., Wood, R. ., Tritton, T. ., Castillo, C. ., … Ismaila, A. S. (2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 2039–2054. http://doi.org/10.2147/copd.s408688
Requena, G. ., Czira, A. ., Banks, V. ., Wood, R. ., Tritton, T. ., Castillo, C. M., … Ismaila, A. S. (2023). Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 1431–1444. http://doi.org/10.2147/copd.s411437
Czira, A. ., Requena, G. ., Banks, V. ., Wood, R. ., Tritton, T. ., Castillo, C. M., … Ismaila, A. S. (2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 18, 643–659. http://doi.org/10.2147/copd.s405498
Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2023). Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 18, 231–245. http://doi.org/10.2147/copd.s389281
Halpin, D. M. G., Rothnie, K. J., Banks, V. ., Czira, A. ., Compton, C. ., Wood, R. ., … Vogelmeier, C. F. (2022). Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. Int J Chron Obstruct Pulmon Dis, 17, 2417–2429. http://doi.org/10.2147/copd.s370540
Czira, A. ., Banks, V. ., Requena, G. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2022). Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England. BMJ Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2022-001243
Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2022). Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist Dual Therapy in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 17, 1781–1795. http://doi.org/10.2147/copd.s365480
Seesaghur, A. ., Petruski-Ivleva, N. ., Banks, V. ., Wang, J. R., Mattox, P. ., Hoeben, E. ., … Kafatos, G. . (2020). Real-world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK-based electronic health records database. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5171